Product Information
TELMISARTAN-AMLODIPINE 40-10 is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $3.0191 per EA under NDC 00378107693. Its NADAC has been published 167 times since Apr 19, 2023.
Strength
10; 40 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378107693
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
AMLODIPINE BESYLATE; TELMISARTANApproval Type
Generic (ANDA)
FDA Application
ANDA202516On Market Since
9/19/2014
Pharmacological Classes
Price Statistics
The NADAC for TELMISARTAN-AMLODIPINE 40-10 has been published 167 times since Apr 19, 2023, and over the history we have for it it has declined 18.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.0191 per EA |
|---|---|
| All-time high | $3.7199 (May 10, 2023) |
| All-time low | $1.9666 (Aug 21, 2024) |
| 52-week high | $3.0465 |
| 52-week low | $2.4074 |
| Median price | $2.4074 |
| Average price | $2.5146 |
| Largest weekly change | -37.5% (May 17, 2023) |
| Weeks tracked | 167 |
| Tracking since | Apr 19, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the telmisartan and amlodipine market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of TELMISARTAN-AMLODIPINE 40-10?
The current National Average Drug Acquisition Cost (NADAC) for TELMISARTAN-AMLODIPINE 40-10, manufactured by Mylan Pharmaceuticals Inc., is $3.0191 per EA (NDC 00378107693), effective Jun 24, 2026.
How has the price of TELMISARTAN-AMLODIPINE 40-10 changed over time?
Over the history we have for it, the NADAC for TELMISARTAN-AMLODIPINE 40-10 has declined 18.8%. It has been tracked across 167 weekly CMS publications since Apr 19, 2023.
What are the highest and lowest recorded NADAC prices for TELMISARTAN-AMLODIPINE 40-10?
Since Apr 19, 2023, the NADAC for TELMISARTAN-AMLODIPINE 40-10 has ranged from a low of $1.9666 (Aug 21, 2024) to a high of $3.7199 (May 10, 2023), with a median of $2.4074 per EA.
Are there cheaper alternatives to TELMISARTAN-AMLODIPINE 40-10?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TELMISARTAN-AMLODIPINE 40-10, so no direct lower-cost alternative is listed.
Who manufactures TELMISARTAN-AMLODIPINE 40-10?
TELMISARTAN-AMLODIPINE 40-10 (NDC 00378107693) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification